Medical professionals are advising the public to prioritize flu vaccinations this season rather than waiting until the traditional “flu before boo” Halloween deadline. According to Emily Martin, a professor of epidemiology at the University of Michigan’s School of Public Health, recent data from the Centers for Disease Control and Prevention (CDC) indicates a notable increase in influenza cases across the United States.
While it is common to see initial flu activity when students return to school, Martin notes that current levels of transmission appear to be persisting. She emphasizes that immunity takes approximately two weeks to develop after vaccination, making early接种 particularly important if an early surge is underway. October remains the optimal window, as it provides protection through the typical peak season of January and February.
Experts caution against delaying until later in the year or getting vaccinated too early in summer. Protection can wane over time, so doses administered in June or July may offer diminished efficacy by winter. However, Martin stresses that receiving any flu shot is significantly better than remaining unvaccinated.
This season introduces a significant advancement: the FDA has approved mFlusiva, an mRNA-based flu vaccine produced by Moderna, for adults aged 50 and older. A study published in May 2026 found that this new formulation was up to 27% more effective at preventing influenza than four existing standard flu shots.
The CDC reports that during the 2024–2025 season, flu vaccinations prevented an estimated 10 million illnesses, 180,000 hospitalizations, and 12,000 deaths. Despite these benefits, vaccination rates have declined; childhood immunization dropped from 63% in the 2019–2020 season to 50% in 2024–2025. Consequently, approximately 300 children died from flu complications last season, the majority of whom were unvaccinated.
Recent political developments have added complexity to the landscape. The Trump Administration recently attempted to revise childhood immunization schedules, a move that would have removed the seasonal flu vaccine from routine recommendations for children. Although President Trump signed an executive order in August reflecting these changes, legal experts note the order lacks legal force. A federal judge previously blocked a similar directive issued under Health and Human Services Secretary Robert F. Kennedy Jr.
Official guidance from the CDC, the American Medical Association, and the American Academy of Pediatrics (AAP) remains unchanged: everyone aged 6 months and older should receive a flu vaccine. Dr. Ashlesha Kaushik, a pediatric infectious disease specialist and AAP spokesperson, criticized the administrative efforts for creating confusion among parents and clinicians without altering the underlying scientific evidence.
“Vaccines shouldn’t be a political discussion. They are scientific tools that have done a great job at preventing infections and deaths,” Kaushik stated. She highlighted that flu vaccination reduces the risk of death from influenza in children by 80%, describing it as the best defense against severe complications and hospitalization.
Leave a Reply